Amlodipine, Valsartan, Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 64380-201

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Amlodipine, Valsartan, Hydrochlorothiazide (NDC 64380-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amlodipine-structure (516dd621 45ae 4fc8 8507 23d43b6d7a7e 40)

FDA Label Image

Valsartan-structure (516dd621 45ae 4fc8 8507 23d43b6d7a7e 41)

FDA Label Image

Hctz-structure (516dd621 45ae 4fc8 8507 23d43b6d7a7e 42)

FDA Label Image

Figure1 (516dd621 45ae 4fc8 8507 23d43b6d7a7e 43)

The figure shows the reduction in mean blood pressure at endpoint. It includes the values of Diastolic BP and Systolic BP.*

FDA Label Image

Figure2 (516dd621 45ae 4fc8 8507 23d43b6d7a7e 44)

FDA Label Image

Figure3 (516dd621 45ae 4fc8 8507 23d43b6d7a7e 45)

The text is describing a figure showing the mean sitting systolic blood pressure by treatment and week. The mean sitting systolic blood pressure measurements are in mmkg. The figure shows the measurements for four different treatments administered over eight weeks. The four treatments include AMINAVHCTZ 10/32025 Mg, Va/KCTZ 32025 mg, Ami/al 10/620 mg, and HCTZAmI25/10 mg. The y-axis shows the measurements in increments of 10, ranging from 120 to 180. The x-axis shows the week of treatment.*

FDA Label Image

Figure4 (516dd621 45ae 4fc8 8507 23d43b6d7a7e 46)

The text provides a figure showing Diastolic Blood Pressure measurements at different times after a dose of treatment for two different drug doses. The figure indicates that higher doses of the drug result in lower blood pressure measurements. No other information or context is provided.*

FDA Label Image

Figure5 (516dd621 45ae 4fc8 8507 23d43b6d7a7e 47)

FDA Label Image

5 mg/160 mg/12.5 mg (30 tablets)

This is a description of a medication label. The medication name is Amlodipine/Valsartan/Hydrochlorothiazide Tablets, manufactured by Strides Pharma Inc. The label contains information about the ingredients and dosage of the medication. It also provides instructions for storage and usage, warning to keep it out of children's reach, and the company's contact information. There is also some information about the packaging design and dimensions of the tablet.*

FDA Label Image

5 mg/160 mg/25 mg (30 tablets)

FDA Label Image

10 mg/160 mg/12.5 mg (30 tablets)

This is a label for medication tablets with amlodipine besylate as the main ingredient, with other ingredients listed such as Valsartan and Hydrochlorothiazide. It contains storage instructions and a warning to keep this medication and all drugs out of reach of children. It also includes information on the number of tablets per container and the radius of the corner of the label itself.*

FDA Label Image

10 mg/160 mg/25 mg (30 tablets)

FDA Label Image

Image (516dd621 45ae 4fc8 8507 23d43b6d7a7e 52)

This is a medicine label for a pack of tablets containing 139 mg of amlodipine besylate. Its NDC number is 64380-201-01. The label contains the dosage recommendation and safety warnings such as keeping the medicine out of children's reach and storage instructions. The tablet has a corner radius of 0.125 inches.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.